Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

Alterations of Methionine Metabolism as Potential Targets for the Prevention and Therapy of Hepatocellular Carcinoma.

Pascale RM, Peitta G, Simile MM, Feo F.

Medicina (Kaunas). 2019 Jun 21;55(6). pii: E296. doi: 10.3390/medicina55060296. Review.

2.

MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes.

Simile MM, Peitta G, Tomasi ML, Brozzetti S, Feo CF, Porcu A, Cigliano A, Calvisi DF, Feo F, Pascale RM.

Oncotarget. 2019 Apr 19;10(29):2835-2854. doi: 10.18632/oncotarget.26838. eCollection 2019 Apr 19.

3.

New insights on liver carcinogenesis.

Feo F.

Transl Gastroenterol Hepatol. 2018 Aug 2;3:50. doi: 10.21037/tgh.2018.07.14. eCollection 2018. No abstract available.

4.

Alterations of methionine metabolism in hepatocarcinogenesis: the emergent role of glycine N-methyltransferase in liver injury.

Simile MM, Latte G, Feo CF, Feo F, Calvisi DF, Pascale RM.

Ann Gastroenterol. 2018 Sep-Oct;31(5):552-560. doi: 10.20524/aog.2018.0288. Epub 2018 Jul 12. Review.

5.

The complex role of bone morphogenetic protein 9 in liver damage and regeneration: New evidence from in vivo and in vitro studies.

Pascale RM, Feo F, Calvisi DF.

Liver Int. 2018 Sep;38(9):1547-1549. doi: 10.1111/liv.13925. No abstract available.

PMID:
30145848
6.

Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma.

Pascale RM, Feo CF, Calvisi DF, Feo F.

Transl Gastroenterol Hepatol. 2018 Jun 29;3:36. doi: 10.21037/tgh.2018.06.04. eCollection 2018. Review.

7.

Sulfatase 1: a new Jekyll and Hyde in hepatocellular carcinoma?

Pascale RM, Calvisi DF, Feo F.

Transl Gastroenterol Hepatol. 2016 May 18;1:43. doi: 10.21037/tgh.2016.05.04. eCollection 2016. No abstract available.

8.

DNA-PKcs: A promising therapeutic target in human hepatocellular carcinoma?

Pascale RM, Joseph C, Latte G, Evert M, Feo F, Calvisi DF.

DNA Repair (Amst). 2016 Nov;47:12-20. doi: 10.1016/j.dnarep.2016.10.004. Epub 2016 Oct 15. Review.

PMID:
27789167
9.

An infernal cross-talk between oncogenic β-catenin and c-Met in hepatocellular carcinoma: Evidence from mouse modeling.

Pascale RM, Feo F, Calvisi DF.

Hepatology. 2016 Nov;64(5):1421-1423. doi: 10.1002/hep.28790. Epub 2016 Sep 30. No abstract available.

PMID:
27596836
10.

Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease.

Simile MM, Latte G, Demartis MI, Brozzetti S, Calvisi DF, Porcu A, Feo CF, Seddaiu MA, Daino L, Berasain C, Tomasi ML, Avila MA, Feo F, Pascale RM.

Oncotarget. 2016 Aug 2;7(31):49194-49216. doi: 10.18632/oncotarget.10246.

11.

Focal loss of long non-coding RNA-PRAL, as determinant of cell function and phenotype of hepatocellular carcinoma.

Feo F, Simile MM, Pascale RM.

Ann Transl Med. 2016 May;4(9):183. doi: 10.21037/atm.2016.03.47. No abstract available.

12.

Simultaneous detection of multiple lower genital tract pathogens by an impedimetric immunochip.

Chiriacò MS, Primiceri E, De Feo F, Montanaro A, Monteduro AG, Tinelli A, Megha M, Carati D, Maruccio G.

Biosens Bioelectron. 2016 May 15;79:9-14. doi: 10.1016/j.bios.2015.11.100. Epub 2015 Dec 3.

PMID:
26686917
13.

Portable gliadin-immunochip for contamination control on the food production chain.

Chiriacò MS, de Feo F, Primiceri E, Monteduro AG, de Benedetto GE, Pennetta A, Rinaldi R, Maruccio G.

Talanta. 2015 Sep 1;142:57-63. doi: 10.1016/j.talanta.2015.04.040. Epub 2015 Apr 23.

PMID:
26003692
14.

Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis?

Feo F, Pascale RM.

Ann Transl Med. 2015 Jan;3(1):4. doi: 10.3978/j.issn.2305-5839.2014.12.08.

15.

HLA-DRA variants predict penicillin allergy in genome-wide fine-mapping genotyping.

Guéant JL, Romano A, Cornejo-Garcia JA, Oussalah A, Chery C, Blanca-López N, Guéant-Rodriguez RM, Gaeta F, Rouyer P, Josse T, Canto G, Carmona FD, Bossini-Castillo L, Martin J, Laguna JJ, Fernandez J, Feo F, Ostrov DA, Plasencia PC, Mayorga C, Torres MJ, Blanca M.

J Allergy Clin Immunol. 2015 Jan;135(1):253-9. doi: 10.1016/j.jaci.2014.07.047. Epub 2014 Sep 12.

PMID:
25224099
16.

New insights on the role of epigenetic alterations in hepatocellular carcinoma.

Frau M, Feo CF, Feo F, Pascale RM.

J Hepatocell Carcinoma. 2014 Jun 12;1:65-83. doi: 10.2147/JHC.S44506. eCollection 2014. Review.

17.

Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value.

Evert M, Frau M, Tomasi ML, Latte G, Simile MM, Seddaiu MA, Zimmermann A, Ladu S, Staniscia T, Brozzetti S, Solinas G, Dombrowski F, Feo F, Pascale RM, Calvisi DF.

Br J Cancer. 2013 Nov 12;109(10):2654-64. doi: 10.1038/bjc.2013.606. Epub 2013 Oct 17.

18.

A topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study).

Ojeda P, Piqué N, Alonso A, Delgado J, Feo F, Igea JM, Navarro A, Olaguibel JM, Subiza J, Nieto C, Andersson M.

Allergy Asthma Clin Immunol. 2013 Aug 27;9(1):32. doi: 10.1186/1710-1492-9-32.

19.

On-chip screening for prostate cancer: an EIS microfluidic platform for contemporary detection of free and total PSA.

Chiriacò MS, Primiceri E, Montanaro A, de Feo F, Leone L, Rinaldi R, Maruccio G.

Analyst. 2013 Sep 21;138(18):5404-10. doi: 10.1039/c3an00911d. Epub 2013 Jul 25.

PMID:
23884165
20.

Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.

Frau M, Feo F, Pascale RM.

J Hepatol. 2013 Oct;59(4):830-41. doi: 10.1016/j.jhep.2013.04.031. Epub 2013 May 7. Review.

21.

Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: novel insights from interspecies comparison.

Calvisi DF, Frau M, Tomasi ML, Feo F, Pascale RM.

Biochim Biophys Acta. 2012 Aug;1826(1):215-37. Review.

PMID:
23393659
22.

Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system.

Latasa MU, Salis F, Urtasun R, Garcia-Irigoyen O, Elizalde M, Uriarte I, Santamaria M, Feo F, Pascale RM, Prieto J, Berasain C, Avila MA.

PLoS One. 2012;7(12):e52711. doi: 10.1371/journal.pone.0052711. Epub 2012 Dec 20.

23.

Visual field loss morphology in high- and normal-tension glaucoma.

Iester M, De Feo F, Douglas GR.

J Ophthalmol. 2012;2012:327326. doi: 10.1155/2012/327326. Epub 2012 Feb 8.

24.

An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis.

Frau M, Simile MM, Tomasi ML, Demartis MI, Daino L, Seddaiu MA, Brozzetti S, Feo CF, Massarelli G, Solinas G, Feo F, Lee JS, Pascale RM.

Cell Oncol (Dordr). 2012 Jun;35(3):163-73. doi: 10.1007/s13402-011-0067-z. Epub 2012 Mar 21.

25.

Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.

Frau M, Tomasi ML, Simile MM, Demartis MI, Salis F, Latte G, Calvisi DF, Seddaiu MA, Daino L, Feo CF, Brozzetti S, Solinas G, Yamashita S, Ushijima T, Feo F, Pascale RM.

Hepatology. 2012 Jul;56(1):165-75. doi: 10.1002/hep.25643. Epub 2012 Jun 5.

PMID:
22318685
26.

[MALDI-TOF and SELDI-TOF analysis: "tandem" techniques to identify potential biomarker in fibromyalgia].

Giacomelli C, Bazzichi L, Giusti L, Ciregia F, Baldini C, Da Valle Y, De Feo F, Sernissi F, Rossi A, Bombardieri S, Lucacchini A.

Reumatismo. 2011 Nov 9;63(3):165-70. doi: 10.4081/reumatismo.2011.165. Italian.

PMID:
22257917
27.

Connective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation.

Urtasun R, Latasa MU, Demartis MI, Balzani S, Goñi S, Garcia-Irigoyen O, Elizalde M, Azcona M, Pascale RM, Feo F, Bioulac-Sage P, Balabaud C, Muntané J, Prieto J, Berasain C, Avila MA.

Hepatology. 2011 Dec;54(6):2149-58. doi: 10.1002/hep.24587.

PMID:
21800344
28.

Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.

Calvisi DF, Simile MM, Ladu S, Frau M, Evert M, Tomasi ML, Demartis MI, Daino L, Seddaiu MA, Brozzetti S, Feo F, Pascale RM.

Hepatology. 2011 Apr;53(4):1226-36. doi: 10.1002/hep.24174.

PMID:
21480327
29.

Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.

Frau M, Ladu S, Calvisi DF, Simile MM, Bonelli P, Daino L, Tomasi ML, Seddaiu MA, Feo F, Pascale RM.

J Hepatol. 2011 Jul;55(1):111-9. doi: 10.1016/j.jhep.2010.10.031. Epub 2010 Dec 7.

PMID:
21419759
30.

Spasmophilia comorbidity in fibromyalgia syndrome.

Bazzichi L, Consensi A, Rossi A, Giacomelli C, De Feo F, Doveri M, Sernissi F, Calabrese R, Consoli G, Ciapparelli A, Dell'Osso L, Bombardieri S.

Clin Exp Rheumatol. 2010 Nov-Dec;28(6 Suppl 63):S94-9. Epub 2010 Dec 22.

PMID:
21176428
31.

Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis?

Giusti L, Baldini C, Ciregia F, Giannaccini G, Giacomelli C, De Feo F, Delle Sedie A, Riente L, Lucacchini A, Bazzichi L, Bombardieri S.

Proteomics Clin Appl. 2010 Mar;4(3):315-24. doi: 10.1002/prca.200900082. Epub 2010 Jan 4.

PMID:
21137052
32.

Agreement to detect glaucomatous visual field progression by using three different methods: a multicentre study.

Iester M, Capris E, De Feo F, Polvicino M, Brusini P, Capris P, Corallo G, Figus M, Fogagnolo P, Frezzotti P, Manni G, Perdicchi A.

Br J Ophthalmol. 2011 Sep;95(9):1276-83. doi: 10.1136/bjo.2010.189456. Epub 2010 Dec 3.

PMID:
21131377
33.

A proposal of simple calculation (ERI calculator) to predict the early response to TNF-α blockers therapy in rheumatoid arthritis.

Bazzichi L, Rossi P, Giacomelli C, De Feo F, Bobbio-Pallavicini F, Rossi A, Baldini C, Consensi A, Doveri M, Bonino C, Mazzantini M, Della Rossa A, Montecucco C, Bombardieri S.

Rheumatol Int. 2012 Feb;32(2):349-56. doi: 10.1007/s00296-010-1619-7. Epub 2010 Nov 26.

PMID:
21110028
34.

Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia?

Bazzichi L, Rossi A, Zirafa C, Monzani F, Tognini S, Dardano A, Santini F, Tonacchera M, De Servi M, Giacomelli C, De Feo F, Doveri M, Massimetti G, Bombardieri S.

Rheumatol Int. 2012 Feb;32(2):335-41. doi: 10.1007/s00296-010-1620-1. Epub 2010 Nov 18.

PMID:
21085966
35.

Evaluation of the stomatognathic system in patients with rheumatoid arthritis according to the research diagnostic criteria for temporomandibular disorders.

Bracco P, Debernardi C, Piancino MG, Cirigliano MF, Salvetti G, Bazzichi L, De Feo F, Bosco M.

Cranio. 2010 Jul;28(3):181-6.

PMID:
20806736
36.

[Generalized secondary peritonitis: predictors of in-hospital mortality and survival and mortality evolutive links].

Berreta J, Kociak D, Balducci A, De Feo F, Laplacette MV, Bellido F, Fabiana Vázquez M, González Fernández E, Brotto C, Barrios A, Bressan T.

Acta Gastroenterol Latinoam. 2010 Jun;40(2):105-16. Spanish.

PMID:
20645557
37.

S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes.

Tomasi ML, Ramani K, Lopitz-Otsoa F, Rodríguez MS, Li TW, Ko K, Yang H, Bardag-Gorce F, Iglesias-Ara A, Feo F, Pascale MR, Mato JM, Lu SC.

Hepatology. 2010 Jun;51(6):2152-61. doi: 10.1002/hep.23530.

38.

Special issue on "molecular mechanisms and new therapeutic targets in human carcinogenesis".

Feo F, Poli G.

Mol Aspects Med. 2010 Apr;31(2):133-4. doi: 10.1016/j.mam.2010.02.002. Epub 2010 Feb 20. No abstract available.

PMID:
20176051
39.

Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.

Frau M, Biasi F, Feo F, Pascale RM.

Mol Aspects Med. 2010 Apr;31(2):179-93. doi: 10.1016/j.mam.2010.02.007. Epub 2010 Feb 20. Review.

PMID:
20176048
40.

SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.

Calvisi DF, Ladu S, Pinna F, Frau M, Tomasi ML, Sini M, Simile MM, Bonelli P, Muroni MR, Seddaiu MA, Lim DS, Feo F, Pascale RM.

Gastroenterology. 2009 Nov;137(5):1816-26.e1-10. doi: 10.1053/j.gastro.2009.08.005. Epub 2009 Aug 15.

PMID:
19686743
41.

Cell-free DNA in the plasma of patients with systemic sclerosis.

Mosca M, Giuliano T, Cuomo G, Doveri M, Tani C, Curcio M, Abignano G, De Feo F, Bazzichi L, Della Rossa A, Valentini G, Bombardieri S.

Clin Rheumatol. 2009 Dec;28(12):1437-40. doi: 10.1007/s10067-009-1245-5. Epub 2009 Aug 11.

PMID:
19669854
42.

Efficacy and safety of a steel drainage device implanted under a scleral flap.

De Feo F, Bagnis A, Bricola G, Scotto R, Traverso CE.

Can J Ophthalmol. 2009 Aug;44(4):457-62. doi: 10.3129/i09-120.

PMID:
19606171
43.

Osteopontin is associated with increased arterial stiffness in rheumatoid arthritis.

Bazzichi L, Ghiadoni L, Rossi A, Bernardini M, Lanza M, De Feo F, Giacomelli C, Mencaroni I, Raimo K, Rossi M, Mazzone AM, Taddei S, Bombardieri S.

Mol Med. 2009 Nov-Dec;15(11-12):402-6. doi: 10.2119/molmed.2009.00052. Epub 2009 Jun 18.

44.

The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease.

Calvisi DF, Pinna F, Ladu S, Muroni MR, Frau M, Demartis I, Tomasi ML, Sini M, Simile MM, Seddaiu MA, Feo F, Pascale RM.

Int J Cancer. 2010 Mar 1;126(5):1275-81. doi: 10.1002/ijc.24650.

45.

Histological biocompatibility of a stainless steel miniature glaucoma drainage device in humans: a case report.

De Feo F, Jacobson S, Nyska A, Pagani P, Traverso CE.

Toxicol Pathol. 2009 Jun;37(4):512-6. doi: 10.1177/0192623309336150.

PMID:
19458389
46.

Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma.

Feo F, Frau M, Tomasi ML, Brozzetti S, Pascale RM.

Exp Biol Med (Maywood). 2009 Jul;234(7):726-36. doi: 10.3181/0901-MR-40. Epub 2009 May 8. Review.

PMID:
19429855
47.

Muscle modifications in fibromyalgic patients revealed by surface electromyography (SEMG) analysis.

Bazzichi L, Dini M, Rossi A, Corbianco S, De Feo F, Giacomelli C, Zirafa C, Ferrari C, Rossi B, Bombardieri S.

BMC Musculoskelet Disord. 2009 Apr 15;10:36. doi: 10.1186/1471-2474-10-36.

48.

Altered amino acid homeostasis in subjects affected by fibromyalgia.

Bazzichi L, Palego L, Giannaccini G, Rossi A, De Feo F, Giacomelli C, Betti L, Giusti L, Mascia G, Bombardieri S, Lucacchini A.

Clin Biochem. 2009 Jul;42(10-11):1064-70. doi: 10.1016/j.clinbiochem.2009.02.025. Epub 2009 Mar 10.

PMID:
19281806
49.

Correlation between total annual atmospheric pollen counts for Chenopodiaceae--Amaranthaceae and the prevalence of positive skin prick tests to Chenopodium and/or Salsola pollen extracts: a multicenter study.

Pola J, Subiza J, Zapata C, Moral A, Feo F; Aerobiology Committee of the Spanish Society of Allergology and Clinical Immunology.

J Investig Allergol Clin Immunol. 2009;19(1):73-4. No abstract available.

50.

Magnetic resonance imaging in patients implanted with Ex-PRESS stainless steel glaucoma drainage microdevice.

De Feo F, Roccatagliata L, Bonzano L, Castelletti L, Mancardi G, Traverso CE.

Am J Ophthalmol. 2009 May;147(5):907-11, 911.e1. doi: 10.1016/j.ajo.2008.12.011. Epub 2009 Feb 20.

PMID:
19232564

Supplemental Content

Support Center